Bone health and prevalent fractures in women with polycystic ovary syndrome: a meta-analysis and endocrine-context pathophysiology review
Expert Rev Endocrinol Metab. 2023 May 30:1-11. doi: 10.1080/17446651.2023.2216294. Online ahead of print.ABSTRACTINTRODUCTION: Bone health in those with Polycystic Ovary Syndrome (PCOS) is complex, but the general consensus is that cortical areal bone mineral density (aBMD) sites will be higher in PCOS than in age- and BMI-similar controls. However, spine aBMD sites may be lower, especially in non-obese PCOS. Whether or not incident fracture risk is increased in PCOS is currently controversial; no meta-analysis has yet assessed prevalent fractures.AREAS COVERED: We assessed the bone effects of PCOS-related ovarian hormone ...
Source: Expert Review of Endocrinology and Metabolism - May 31, 2023 Category: Endocrinology Authors: Jerilynn C Prior Sonia Shirin Azita Goshtasebi Source Type: research

Finding the most cost-effective option from commonly used Dipeptidyl peptidase-4 inhibitors in India: a systematic study
CONCLUSIONS: Teneligliptin 20 mg could be considered as the preferred and most cost-effective agent among commonly used DPP4Is for the effective management of patients with T2DM in India.PMID:37232153 | DOI:10.1080/17446651.2023.2216279 (Source: Expert Review of Endocrinology and Metabolism)
Source: Expert Review of Endocrinology and Metabolism - May 26, 2023 Category: Endocrinology Authors: Harmanjit Singh Ekta Arora Seerat Narula Mandeep Singla Armaan Otaal Jatin Sharma Source Type: research

Intranasal oxytocin as a treatment for obesity: safety and efficacy
Expert Rev Endocrinol Metab. 2023 May 26:1-12. doi: 10.1080/17446651.2023.2216794. Online ahead of print.ABSTRACTINTRODUCTION: Known for its effect on labor and lactation and on emotional and social functions, oxytocin has recently emerged as a key modulator of feeding behavior and indeed suggested as a potential treatment for obesity. The potential positive effect of oxytocin on both metabolic and psychological-behavioral complications of hypothalamic lesions makes it a promising tool in the management of these conditions.AREAS COVERED: The aim of the present review article is to provide an overview of the mechanism of ac...
Source: Expert Review of Endocrinology and Metabolism - May 26, 2023 Category: Endocrinology Authors: Roberta Balestrino Marco Losa Luigi Albano Lina R Barzaghi Pietro Mortini Source Type: research

Finding the most cost-effective option from commonly used Dipeptidyl peptidase-4 inhibitors in India: a systematic study
CONCLUSIONS: Teneligliptin 20 mg could be considered as the preferred and most cost-effective agent among commonly used DPP4Is for the effective management of patients with T2DM in India.PMID:37232153 | DOI:10.1080/17446651.2023.2216279 (Source: Expert Review of Endocrinology and Metabolism)
Source: Expert Review of Endocrinology and Metabolism - May 26, 2023 Category: Endocrinology Authors: Harmanjit Singh Ekta Arora Seerat Narula Mandeep Singla Armaan Otaal Jatin Sharma Source Type: research

Intranasal oxytocin as a treatment for obesity: safety and efficacy
Expert Rev Endocrinol Metab. 2023 May 26:1-12. doi: 10.1080/17446651.2023.2216794. Online ahead of print.ABSTRACTINTRODUCTION: Known for its effect on labor and lactation and on emotional and social functions, oxytocin has recently emerged as a key modulator of feeding behavior and indeed suggested as a potential treatment for obesity. The potential positive effect of oxytocin on both metabolic and psychological-behavioral complications of hypothalamic lesions makes it a promising tool in the management of these conditions.AREAS COVERED: The aim of the present review article is to provide an overview of the mechanism of ac...
Source: Expert Review of Endocrinology and Metabolism - May 26, 2023 Category: Endocrinology Authors: Roberta Balestrino Marco Losa Luigi Albano Lina R Barzaghi Pietro Mortini Source Type: research

Finding the most cost-effective option from commonly used Dipeptidyl peptidase-4 inhibitors in India: a systematic study
CONCLUSIONS: Teneligliptin 20 mg could be considered as the preferred and most cost-effective agent among commonly used DPP4Is for the effective management of patients with T2DM in India.PMID:37232153 | DOI:10.1080/17446651.2023.2216279 (Source: Expert Review of Endocrinology and Metabolism)
Source: Expert Review of Endocrinology and Metabolism - May 26, 2023 Category: Endocrinology Authors: Harmanjit Singh Ekta Arora Seerat Narula Mandeep Singla Armaan Otaal Jatin Sharma Source Type: research

Intranasal oxytocin as a treatment for obesity: safety and efficacy
Expert Rev Endocrinol Metab. 2023 May 26:1-12. doi: 10.1080/17446651.2023.2216794. Online ahead of print.ABSTRACTINTRODUCTION: Known for its effect on labor and lactation and on emotional and social functions, oxytocin has recently emerged as a key modulator of feeding behavior and indeed suggested as a potential treatment for obesity. The potential positive effect of oxytocin on both metabolic and psychological-behavioral complications of hypothalamic lesions makes it a promising tool in the management of these conditions.AREAS COVERED: The aim of the present review article is to provide an overview of the mechanism of ac...
Source: Expert Review of Endocrinology and Metabolism - May 26, 2023 Category: Endocrinology Authors: Roberta Balestrino Marco Losa Luigi Albano Lina R Barzaghi Pietro Mortini Source Type: research

Finding the most cost-effective option from commonly used Dipeptidyl peptidase-4 inhibitors in India: a systematic study
CONCLUSIONS: Teneligliptin 20 mg could be considered as the preferred and most cost-effective agent among commonly used DPP4Is for the effective management of patients with T2DM in India.PMID:37232153 | DOI:10.1080/17446651.2023.2216279 (Source: Expert Review of Endocrinology and Metabolism)
Source: Expert Review of Endocrinology and Metabolism - May 26, 2023 Category: Endocrinology Authors: Harmanjit Singh Ekta Arora Seerat Narula Mandeep Singla Armaan Otaal Jatin Sharma Source Type: research

Intranasal oxytocin as a treatment for obesity: safety and efficacy
Expert Rev Endocrinol Metab. 2023 May 26:1-12. doi: 10.1080/17446651.2023.2216794. Online ahead of print.ABSTRACTINTRODUCTION: Known for its effect on labor and lactation and on emotional and social functions, oxytocin has recently emerged as a key modulator of feeding behavior and indeed suggested as a potential treatment for obesity. The potential positive effect of oxytocin on both metabolic and psychological-behavioral complications of hypothalamic lesions makes it a promising tool in the management of these conditions.AREAS COVERED: The aim of the present review article is to provide an overview of the mechanism of ac...
Source: Expert Review of Endocrinology and Metabolism - May 26, 2023 Category: Endocrinology Authors: Roberta Balestrino Marco Losa Luigi Albano Lina R Barzaghi Pietro Mortini Source Type: research